ResearcherVan Andel InstituteActive in the last 2 years
Ben Staal
Matched on ORCID iD 0009-0001-0008-4588; OpenAlex author ID A5051050776. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 4
- Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples. Co-author DOI 10.1126/sciadv.adt0029↗
- A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. Co-author DOI 10.1016/j.canlet.2024.217245↗
- Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Co-author DOI 10.1158/1078-0432.ccr-20-2475↗
- The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Co-author DOI 10.1158/1078-0432.ccr-18-3310↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Randall E. Brand · 4 shared papers, 2019–2025 · strength 0.55
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Brian B. Haab · 4 shared papers, 2019–2025 · strength 0.55
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Ying Huang · 4 shared papers, 2019–2025 · strength 0.55
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- ChongFeng Gao · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Aatur Dilip Singhi · 3 shared papers, 2019–2025 · strength 0.38
- Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Peter J. Allen · 2 shared papers, 2021–2025 · strength 0.30
- Anirban Maitra · 2 shared papers, 2019–2024 · strength 0.25
- Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Braelyn Binkowski · 1 shared paper, 2025 · strength 0.20
- Chanjuan Shi · 1 shared paper, 2025 · strength 0.20
- Steve Gallinger · 1 shared paper, 2025 · strength 0.20
- Daniel Barnett · 2 shared papers, 2019–2021 · strength 0.18
- Richard R. Drake · 2 shared papers, 2019–2021 · strength 0.18
- Christine Worthington · 1 shared paper, 2024 · strength 0.16
- Lynette M. Smith · 1 shared paper, 2024 · strength 0.16
- Johannes Francois Fahrmann · 1 shared paper, 2024 · strength 0.16
- Samir Hanash · 1 shared paper, 2024 · strength 0.16
- Anna E. Lokshin · 1 shared paper, 2024 · strength 0.16
- Surinder K. Batra · 1 shared paper, 2024 · strength 0.16
- Maneesh Jain · 1 shared paper, 2024 · strength 0.16
- Sushil Kumar K · 1 shared paper, 2024 · strength 0.16
- Ying Liu · 1 shared paper, 2021 · strength 0.10
- Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10
- Luke Wisniewski · 1 shared paper, 2021 · strength 0.10
- Mohammed Aldakkak · 1 shared paper, 2021 · strength 0.10
- Douglas B. Evans · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.